IBDEI0NT ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24023,1,3,0)
 ;;=3^Low Income
 ;;^UTILITY(U,$J,358.3,24023,1,4,0)
 ;;=4^Z59.6
 ;;^UTILITY(U,$J,358.3,24023,2)
 ;;=^5063135
 ;;^UTILITY(U,$J,358.3,24024,0)
 ;;=Z59.7^^92^1110^6
 ;;^UTILITY(U,$J,358.3,24024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24024,1,3,0)
 ;;=3^Insufficient Social Insurance/Welfare Support
 ;;^UTILITY(U,$J,358.3,24024,1,4,0)
 ;;=4^Z59.7
 ;;^UTILITY(U,$J,358.3,24024,2)
 ;;=^5063136
 ;;^UTILITY(U,$J,358.3,24025,0)
 ;;=Z59.9^^92^1110^4
 ;;^UTILITY(U,$J,358.3,24025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24025,1,3,0)
 ;;=3^Housing/Economic Problems,Unspec
 ;;^UTILITY(U,$J,358.3,24025,1,4,0)
 ;;=4^Z59.9
 ;;^UTILITY(U,$J,358.3,24025,2)
 ;;=^5063138
 ;;^UTILITY(U,$J,358.3,24026,0)
 ;;=G21.19^^92^1111^10
 ;;^UTILITY(U,$J,358.3,24026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24026,1,3,0)
 ;;=3^Medication-Induced Parkinsonism,Other
 ;;^UTILITY(U,$J,358.3,24026,1,4,0)
 ;;=4^G21.19
 ;;^UTILITY(U,$J,358.3,24026,2)
 ;;=^5003773
 ;;^UTILITY(U,$J,358.3,24027,0)
 ;;=G21.11^^92^1111^13
 ;;^UTILITY(U,$J,358.3,24027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24027,1,3,0)
 ;;=3^Neuroleptic-Induced Parkinsonism
 ;;^UTILITY(U,$J,358.3,24027,1,4,0)
 ;;=4^G21.11
 ;;^UTILITY(U,$J,358.3,24027,2)
 ;;=^5003772
 ;;^UTILITY(U,$J,358.3,24028,0)
 ;;=G24.01^^92^1111^15
 ;;^UTILITY(U,$J,358.3,24028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24028,1,3,0)
 ;;=3^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,24028,1,4,0)
 ;;=4^G24.01
 ;;^UTILITY(U,$J,358.3,24028,2)
 ;;=^5003784
 ;;^UTILITY(U,$J,358.3,24029,0)
 ;;=G24.09^^92^1111^16
 ;;^UTILITY(U,$J,358.3,24029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24029,1,3,0)
 ;;=3^Tardive Dystonia
 ;;^UTILITY(U,$J,358.3,24029,1,4,0)
 ;;=4^G24.09
 ;;^UTILITY(U,$J,358.3,24029,2)
 ;;=^5003786
 ;;^UTILITY(U,$J,358.3,24030,0)
 ;;=G25.1^^92^1111^11
 ;;^UTILITY(U,$J,358.3,24030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24030,1,3,0)
 ;;=3^Medication-Induced Postural Tremor
 ;;^UTILITY(U,$J,358.3,24030,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,24030,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,24031,0)
 ;;=G25.71^^92^1111^14
 ;;^UTILITY(U,$J,358.3,24031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24031,1,3,0)
 ;;=3^Tardive Akathisia
 ;;^UTILITY(U,$J,358.3,24031,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,24031,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,24032,0)
 ;;=G25.79^^92^1111^9
 ;;^UTILITY(U,$J,358.3,24032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24032,1,3,0)
 ;;=3^Medication-Induced Movement Disorder,Other
 ;;^UTILITY(U,$J,358.3,24032,1,4,0)
 ;;=4^G25.79
 ;;^UTILITY(U,$J,358.3,24032,2)
 ;;=^5003800
 ;;^UTILITY(U,$J,358.3,24033,0)
 ;;=T43.205A^^92^1111^4
 ;;^UTILITY(U,$J,358.3,24033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24033,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
 ;;^UTILITY(U,$J,358.3,24033,1,4,0)
 ;;=4^T43.205A
 ;;^UTILITY(U,$J,358.3,24033,2)
 ;;=^5050540
 ;;^UTILITY(U,$J,358.3,24034,0)
 ;;=T43.205D^^92^1111^5
 ;;^UTILITY(U,$J,358.3,24034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24034,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,24034,1,4,0)
 ;;=4^T43.205D
 ;;^UTILITY(U,$J,358.3,24034,2)
 ;;=^5050541
 ;;^UTILITY(U,$J,358.3,24035,0)
 ;;=T43.205S^^92^1111^6
 ;;^UTILITY(U,$J,358.3,24035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24035,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
 ;;^UTILITY(U,$J,358.3,24035,1,4,0)
 ;;=4^T43.205S
 ;;^UTILITY(U,$J,358.3,24035,2)
 ;;=^5050542
 ;;^UTILITY(U,$J,358.3,24036,0)
 ;;=G25.71^^92^1111^7
 ;;^UTILITY(U,$J,358.3,24036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24036,1,3,0)
 ;;=3^Medication-Induced Acute Akathisia
 ;;^UTILITY(U,$J,358.3,24036,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,24036,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,24037,0)
 ;;=G24.02^^92^1111^8
 ;;^UTILITY(U,$J,358.3,24037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24037,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,24037,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,24037,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,24038,0)
 ;;=G21.0^^92^1111^12
 ;;^UTILITY(U,$J,358.3,24038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24038,1,3,0)
 ;;=3^Neuroleptic Malignant Syndrome
 ;;^UTILITY(U,$J,358.3,24038,1,4,0)
 ;;=4^G21.0
 ;;^UTILITY(U,$J,358.3,24038,2)
 ;;=^5003771
 ;;^UTILITY(U,$J,358.3,24039,0)
 ;;=T50.905A^^92^1111^1
 ;;^UTILITY(U,$J,358.3,24039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24039,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Init Encntr
 ;;^UTILITY(U,$J,358.3,24039,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,24039,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,24040,0)
 ;;=T50.905S^^92^1111^2
 ;;^UTILITY(U,$J,358.3,24040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24040,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Sequela
 ;;^UTILITY(U,$J,358.3,24040,1,4,0)
 ;;=4^T50.905S
 ;;^UTILITY(U,$J,358.3,24040,2)
 ;;=^5052162
 ;;^UTILITY(U,$J,358.3,24041,0)
 ;;=T50.905D^^92^1111^3
 ;;^UTILITY(U,$J,358.3,24041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24041,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,24041,1,4,0)
 ;;=4^T50.905D
 ;;^UTILITY(U,$J,358.3,24041,2)
 ;;=^5052161
 ;;^UTILITY(U,$J,358.3,24042,0)
 ;;=F42.^^92^1112^5
 ;;^UTILITY(U,$J,358.3,24042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24042,1,3,0)
 ;;=3^Obsessive-Compulsive Disorder
 ;;^UTILITY(U,$J,358.3,24042,1,4,0)
 ;;=4^F42.
 ;;^UTILITY(U,$J,358.3,24042,2)
 ;;=^5003568
 ;;^UTILITY(U,$J,358.3,24043,0)
 ;;=F45.22^^92^1112^1
 ;;^UTILITY(U,$J,358.3,24043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24043,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,24043,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,24043,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,24044,0)
 ;;=F63.3^^92^1112^6
 ;;^UTILITY(U,$J,358.3,24044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24044,1,3,0)
 ;;=3^Trichotillomania (Hair-Pulling Disorder)
 ;;^UTILITY(U,$J,358.3,24044,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,24044,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,24045,0)
 ;;=L98.1^^92^1112^2
 ;;^UTILITY(U,$J,358.3,24045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24045,1,3,0)
 ;;=3^Excoriation (Skin-Picking) Disorder
 ;;^UTILITY(U,$J,358.3,24045,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,24045,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,24046,0)
 ;;=F42.^^92^1112^3
 ;;^UTILITY(U,$J,358.3,24046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24046,1,3,0)
 ;;=3^Hoarding Disorder
 ;;^UTILITY(U,$J,358.3,24046,1,4,0)
 ;;=4^F42.
 ;;^UTILITY(U,$J,358.3,24046,2)
 ;;=^5003568
 ;;^UTILITY(U,$J,358.3,24047,0)
 ;;=F06.8^^92^1112^4
 ;;^UTILITY(U,$J,358.3,24047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24047,1,3,0)
 ;;=3^Obsessive-Compulsive & Related Disorder d/t Another Med Condition
 ;;^UTILITY(U,$J,358.3,24047,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,24047,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,24048,0)
 ;;=Z91.49^^92^1113^12
 ;;^UTILITY(U,$J,358.3,24048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24048,1,3,0)
 ;;=3^Personal Hx of Psychological Trauma
 ;;^UTILITY(U,$J,358.3,24048,1,4,0)
 ;;=4^Z91.49
 ;;^UTILITY(U,$J,358.3,24048,2)
 ;;=^5063623
 ;;^UTILITY(U,$J,358.3,24049,0)
 ;;=Z91.5^^92^1113^13
 ;;^UTILITY(U,$J,358.3,24049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24049,1,3,0)
 ;;=3^Personal Hx of Self-Harm
 ;;^UTILITY(U,$J,358.3,24049,1,4,0)
 ;;=4^Z91.5
 ;;^UTILITY(U,$J,358.3,24049,2)
 ;;=^5063624
 ;;^UTILITY(U,$J,358.3,24050,0)
 ;;=Z91.82^^92^1113^11
 ;;^UTILITY(U,$J,358.3,24050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24050,1,3,0)
 ;;=3^Personal Hx of Military Deployment
 ;;^UTILITY(U,$J,358.3,24050,1,4,0)
 ;;=4^Z91.82
 ;;^UTILITY(U,$J,358.3,24050,2)
 ;;=^5063626
